Employer record · East Brunswick, NJ · FY2020–FY2026

Cronus Pharma LLC

    Certified LCAs
    7
    FY2024–FY2026
    USCIS approvals
    3
    1 new employment
    Denial rate
    0.0%
    FY2024–FY2026
    Median wage offered
    $76k
    certified LCAs

    Jobs not indexed yet

    Does Cronus Pharma LLC sponsor H-1B visas?

    Yes — by its record, Cronus Pharma LLC is a small-scale H-1B sponsor: it filed 7 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 3 USCIS H-1B petition approvals (1 for new employment). Its latest certified LCA in our data was decided May 18, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Updated · DOL OFLC LCA disclosure + USCIS H-1B Employer Data Hub

    Filings by fiscal year

    Certified LCAs per U.S. government fiscal year (Oct–Sep) — 13 since FY2020; the slim bar is USCIS petition approvals (new + continuing), the bottom row their approval rate.

    Cronus Pharma LLC certified LCAs by fiscal year
    Fiscal yearcertified LCAsUSCIS approvalsApproval rate
    FY2011100%
    FY2242100%
    FY2311100%
    FY2522100%
    FY2651100%

    Occupations sponsored

    Occupation (SOC)LCAsMedian wage
    Regulatory Affairs Specialists 13-10414$74k
    Marketing Managers 11-20211$200k
    Supply Chain Managers 11-30711$130k
    Data Scientists 15-20511$90k

    Most-filed job titles

    1. Regulatory Affairs Specialist4$74k
    2. Data Management Analyst1$90k
    3. Director Pricing and Commercial Operations1$200k
    4. Director Project Management and Supply Chain Management1$130k

    LCAs per title and median wage offered.

    Where the jobs were

    1. New Jersey7 LCAs

    We haven't indexed Cronus Pharma's jobs yet

    We read jobs straight from employers' own career sites and haven't added Cronus Pharma's yet. Its H-1B record on this page comes from public DOL and USCIS data and is not affected.

    Also filed as

    • CRONUS PHARMA LLC (USCIS)
    • Cronus Pharma LLC (LCA)

    Cronus Pharma LLC H-1B: questions people ask

    Does Cronus Pharma LLC sponsor H-1B visas?

    Yes — by its record, Cronus Pharma LLC is a small-scale H-1B sponsor: it filed 7 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 3 USCIS H-1B petition approvals (1 for new employment). Its latest certified LCA in our data was decided May 18, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Is Cronus Pharma LLC still sponsoring H-1B in 2026?

    Cronus Pharma LLC had 5 certified LCAs in FY2026 (Oct 2025–Sep 2026), more than the 2 in FY2025. The latest one in our data was decided May 18, 2026. An LCA is filed before a petition, so it shows recent intent to hire on H-1B, not a hire.

    How many H-1B petitions does Cronus Pharma LLC get approved?

    USCIS recorded 3 approvals (1 for new employment, the rest continuing employment such as extensions and transfers) and 0 denials for Cronus Pharma LLC in FY2024–FY2026 — a denial rate of 0.0%. Source: USCIS H-1B Employer Data Hub (first decisions).

    What is the H-1B salary at Cronus Pharma LLC?

    The median wage offered on Cronus Pharma LLC's certified LCAs in FY2024–FY2026 was $76k a year. By job title: Regulatory Affairs Specialist $74k (4 LCAs), Data Management Analyst $90k (1 LCAs) and Director Pricing and Commercial Operations $200k (1 LCAs). LCA wages are the pay the employer attested to; actual pay can be higher.

    Which jobs does Cronus Pharma LLC sponsor for H-1B?

    Its certified LCAs in FY2024–FY2026 were mostly for Regulatory Affairs Specialists (4), Marketing Managers (1) and Supply Chain Managers (1).

    Where are Cronus Pharma LLC's H-1B jobs?

    By worksite on its certified LCAs (FY2024–FY2026): New Jersey (7).

    Is Cronus Pharma LLC an H-1B dependent employer?

    No — its recent LCAs do not declare it H-1B dependent.

    Does Cronus Pharma LLC have open jobs?

    We read jobs straight from employers' own career sites and haven't added Cronus Pharma's yet.